115 related articles for article (PubMed ID: 7714974)
21. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
Loran OB; Segal AS; Shcheplev PA
Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
[TBL] [Abstract][Full Text] [Related]
22. Intracavernous injection of prostaglandin E1 in impotent men.
Stackl W; Hasun R; Marberger M
J Urol; 1988 Jul; 140(1):66-8. PubMed ID: 3379700
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
[TBL] [Abstract][Full Text] [Related]
24. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E1 and the nitric oxide donor linsidomine for erectile failure: a diagnostic comparative study of 40 patients.
Porst H
J Urol; 1993 May; 149(5 Pt 2):1280-3. PubMed ID: 8479015
[TBL] [Abstract][Full Text] [Related]
26. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
Beretta G; Zanollo A; Portalupi W
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
[TBL] [Abstract][Full Text] [Related]
27. A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group.
Vanderschueren D; Heyrman RM; Keogh EJ; Casey RW; Weiske WH; Ogrinc FG; de Koning Gans HJ
J Urol; 1995 Nov; 154(5):1744-7. PubMed ID: 7563337
[TBL] [Abstract][Full Text] [Related]
28. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
[TBL] [Abstract][Full Text] [Related]
30. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
Doherty PC; Bivalacqua TJ; Champion HC; Kadowitz PJ; Greenwood-Van Meerveld B; Berzetei-Gurske I; Hellstrom WJ
J Urol; 2001 Mar; 165(3):1004-9. PubMed ID: 11176530
[TBL] [Abstract][Full Text] [Related]
31. A prostaglandin E1 dose-response study in man.
von Heyden B; Donatucci CF; Marshall GA; Brock GB; Lue TF
J Urol; 1993 Dec; 150(6):1825-8. PubMed ID: 8230515
[TBL] [Abstract][Full Text] [Related]
32. Cavernous auto-injection therapy with prostaglandin E1.
Nisén H
Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
[TBL] [Abstract][Full Text] [Related]
33. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
Chen RN; Lakin MM; Montague DK; Ausmundson S
J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
[TBL] [Abstract][Full Text] [Related]
34. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
Beretta G; Marzotto M; Zanollo A; Re B
Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
[TBL] [Abstract][Full Text] [Related]
35. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
36. Treatment of erectile failure with prostaglandin E1: a double-blind, placebo-controlled, dose-response study.
Godschalk MF; Chen J; Katz PG; Mulligan T
J Urol; 1994 Jun; 151(6):1530-2. PubMed ID: 8189563
[TBL] [Abstract][Full Text] [Related]
37. Comparison of penile vascular effect induced by intracavernous injection of papaverine and prostaglandin E1.
Hwang TI; Lue TF; Yang CR; Chang CL; Chang CH; Wu HC
Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1038-41. PubMed ID: 2634727
[TBL] [Abstract][Full Text] [Related]
38. Sodium nitroprusside: physiologic effects as a nitric oxide donor in three species.
Trigo-Rocha F; Martinez-Piñeiro L; Donatucci CF; Hsu GL; Lue TF; Tanagho EA
Int J Impot Res; 1995 Mar; 7(1):49-56. PubMed ID: 7670593
[TBL] [Abstract][Full Text] [Related]
39. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
Polito M; d'Anzeo G; Conti A; Muzzonigro G
BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
[TBL] [Abstract][Full Text] [Related]
40. [The use of PGE1 in the treatment of erectile deficiency].
Arena F; Peracchia G; Di Stefano C; Cortellini P
Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
